多发性脑转移瘤:手术联合术中放疗对比辅助放疗及同期照射未切除病灶
本研究为回顾性剂量学研究,比较脑转移瘤切除腔采用术中放疗(IORT)联合未切除脑转移灶立体定向放疗(SRT)与辅助SRT联合同期SRT的剂量学差异。结果显示IORT+SRT组在全脑剂量暴露各项指标上显著更低,视束最大剂量显著降低。
要点
- IORT+SRT组全脑V12Gy-V30Gy均显著低于辅助SRT+SRT组(p<0.05)。
- 视束D0.035 cm³平均降低57.5%(0.89 Gy vs 2.10 Gy,p=0.040)。
- 脑干D0.035 cm³平均降低37.7%(3.51 Gy vs 5.65 Gy,p=0.292)。
核心结论
- 对于多发性脑转移瘤,切除腔采用IORT联合未切除病灶SRT,较辅助SRT联合同期SRT具有更优的剂量学特性。
研究设计与样本
- 回顾性剂量学研究,纳入10例接受辅助SRT联合同期SRT至未切除脑转移灶的患者和4例接受IORT联合SRT至脑转移灶的患者。
- 对IORT患者进行事后IORT计划计算并与相应SRT计划叠加;辅助SRT组患者作为模板模拟IORT计划并与残留脑转移灶SRT计划叠加。
- 模拟IORT病例与实际IORT病例合并为IORT+SRT组,评估全脑剂量暴露(V12Gy、V18Gy、V20Gy、V24Gy、V25Gy、V30Gy)及脑干和视束最大剂量(D0.035 cm³)。
主要发现
- IORT+SRT组全脑剂量暴露所有指标(V12Gy-V30Gy)均显著低于辅助SRT+SRT组(p<0.05)。
- IORT+SRT组脑干D0.035 cm³平均降低37.7%(3.51 Gy vs 5.65 Gy,p=0.292)。
- IORT+SRT组视束D0.035 cm³平均降低57.5%(0.89 Gy vs 2.10 Gy,p=0.040)。
临床怎么用
- 对于多发性脑转移瘤需手术切除一处病灶并同期处理未切除病灶者,可考虑切除腔IORT联合未切除病灶SRT以降低全脑及危及器官剂量。
- 视束剂量获益具有统计学显著性,脑干剂量降低未达统计学显著性,临床决策需结合个体解剖与剂量约束。
局限性
- 回顾性剂量学研究,样本量小(辅助SRT组10例、IORT组4例)。
- 部分IORT计划为基于辅助SRT组模板的模拟计算,非实际治疗计划。
- 脑干剂量差异未达统计学显著性(p=0.292)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment of multiple brain metastases (BM) often involves surgical resection of one lesion combined with stereotactic radiotherapy (SRT) to the resection cavity and unresected BM. Intraoperative radiotherapy (IORT) is an emerging alternative for treating the resection cavity, potentially dosimetric benefits. This study aimed to compare the dosimetry of treating the resection cavity with IORT versus adjuvant SRT when combined with SRT for additional unresected BM. METHODS: Ten patients with BM who received adjuvant SRT to the resection cavity plus concurrent SRT to additional BM (adjuvant SRT + SRT to BM group) and 4 patients with IORT and SRT to BM were identified. Post-hoc IORT plans were calculated for IORT patients and summed with corresponding SRT plans. Additionally, patients from the adjuvant SRT + SRT to BM group served as templates for IORT simulation and the simulated IORT plans were also summed with the corresponding plans for SRT to residual BM. The simulated IORT cases were then pooled with the actual IORT cases, forming the IORT + SRT to BM group. Brain dose exposure (V12Gy, V18Gy, V20Gy, V24Gy, V25Gy, and V30Gy) and maximum doses (D0.035 cm³) to the brainstem and optic tract were evaluated. RESULTS: The IORT + SRT to BM group showed significantly lower brain dose exposure across all metrics (V12Gy-V30Gy) compared to the adjuvant SRT + SRT to BM group (p < 0.05 for all). Maximum doses to organs at risk were lower in the IORT + SRT to BM group, with mean D0.035 cm³ reduced by 37.7% for the brainstem (3.51 Gy vs. 5.65 Gy, p = 0.292) and significantly reduced by 57.5% for the optic tract (0.89 Gy vs. 2.10 Gy, p = 0.040). CONCLUSIONS: IORT in combination with SRT for additional BM demonstrated superior dosimetric properties compared to adjuvant cavity SRT plus concurrent SRT to BM. TRIAL REGISTRATION: Not applicable (Retrospective dosimetric study).
引用
- Wieger G, Godó Jiménez À, Brehmer S, et al. Multiple brain metastases: resection with IORT versus adjuvant radiotherapy and concurrent irradiation of unresected lesions. Radiat Oncol. 2025. PMID: 41121339. doi:10.1186/s13014-025-02736-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。